AbbVie (ABBV) Tops Q4 EPS by 6c, Offers FY Guidance
Get Alerts ABBV Hot Sheet
Join SI Premium – FREE
AbbVie (NYSE: ABBV) reported Q4 EPS of $2.92, $0.06 better than the analyst estimate of $2.86. Revenue for the quarter came in at $13.86 billion versus the consensus estimate of $13.73 billion.
GUIDANCE:
AbbVie sees FY2021 EPS of $12.32-$12.52, versus the consensus of $12.18.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- SAP SE (SAP) Misses Q1 EPS by 25c; offers outlook
- Cadence (CDNS) tumbles despite Q1 beat on top and bottom lines
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!